Research programme: small molecule therapeutics - Latigo Biotherapeutics
Latest Information Update: 16 Feb 2024
At a glance
- Originator Latigo Biotherapeutics
- Class Non-opioid analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Pain